Market Cap 174.77M
Revenue (ttm) 7.00M
Net Income (ttm) -127.17M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,816.71%
Debt to Equity Ratio 0.00
Volume 1,093,100
Avg Vol 461,524
Day's Range N/A - N/A
Shares Out 62.87M
Stochastic %K 75%
Beta 0.88
Analysts Strong Sell
Price Target $4.00

Company Profile

Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT3789, a selective degrader of SMARCA2 protein for the treatment of advanced or metastatic solid tumors with loss of SMARCA4 due to truncating mutation and/or deletion; PRT7732, a selective and orally bioavailable SMARCA2 degraders to treat advanced or metastatic solid tumors; and PRT2527, a cyclin...

Industry: Biotechnology
Sector: Healthcare
Phone: 302 467 1280
Address:
175 Innovation Boulevard, Wilmington, United States
LabPsycho
LabPsycho Feb. 23 at 3:29 PM
$PRLD I've impressed myself again - see below. From $2.40 to the curious $3.0 target price predictionby LabPsycho's A^2. I. in less than 2 trading days - hit $3 premarket this morning asking $2.94 now.
0 · Reply
Jaybird827
Jaybird827 Feb. 23 at 1:05 PM
$PRLD jumped to 2.99 this Morning 🤔
0 · Reply
EmproX
EmproX Feb. 23 at 1:02 PM
$HLF $PRLD $HYMC $SYRE ’•’•’
0 · Reply
AnalyticaInvestor
AnalyticaInvestor Feb. 23 at 12:15 PM
$QMCO Good morning, investors. Mining and resource linked shares are pushing higher as capital rotates toward tangible assets. On the watchlist, $QMCO is down over 90% YTD but posted a fiscal Q3 revenue beat, with CEO share purchases signaling insider confidence. Among gainers, $RXT surged +37% on an enterprise AI partnership, while $PRLD climbed +22% on oncology progress. On the downside, $VENH fell −33% amid thin liquidity. In volume, $ALIT traded over 46M shares as litigation and earnings headlines drove activity. Read the full Analytica Alpha 👇 https://analyticainvestor.beehiiv.com/p/15-global-tariff-jolt
0 · Reply
Gtrading1234
Gtrading1234 Feb. 22 at 8:24 AM
0 · Reply
StockScanners
StockScanners Feb. 21 at 6:06 AM
$PRLD keep watch if this holds above 2.60
1 · Reply
Jaybird827
Jaybird827 Feb. 20 at 11:28 PM
$PRLD I’m in for the long haul
0 · Reply
Jaybird827
Jaybird827 Feb. 20 at 9:01 PM
$PRLD up today Down to 2.09 Tuesday 🤣
0 · Reply
LabPsycho
LabPsycho Feb. 20 at 8:24 PM
$PRLD Intuitively, compared to other biotechs, the current market cap seems high already, IMO. But LabPsycho's Artificial Artificial Intelligence - A^2. I.- which is exponentially better than just regular ole A.I. has analyzed the trading A.I. Bot's activity on PRLD and has predicted this running to near $3. Dont ask me how or why. Bots psychoanalyzing other bots - Lol. We'll see.
0 · Reply
BDE_Worldwide
BDE_Worldwide Feb. 20 at 8:19 PM
$PRLD low float turd 💩 . But happy to ride along as this gets squeezed like so many other R/S bios that have lost 99% of investors long term capital.. see $PASG for reference.. 🚀 💥
0 · Reply
Latest News on PRLD
Prelude Therapeutics Announces Strategic Business Update

Nov 4, 2025, 7:05 AM EST - 3 months ago

Prelude Therapeutics Announces Strategic Business Update


Prelude Announces Presentations at 2025 AACR Annual Meeting

Apr 25, 2025, 4:05 PM EDT - 10 months ago

Prelude Announces Presentations at 2025 AACR Annual Meeting


Prelude Therapeutics Announces $25 Million Private Placement

Dec 11, 2023, 9:34 AM EST - 2 years ago

Prelude Therapeutics Announces $25 Million Private Placement


Prelude Therapeutics Reports Full Year 2021 Financial Results

Mar 16, 2022, 7:30 AM EDT - 4 years ago

Prelude Therapeutics Reports Full Year 2021 Financial Results


LabPsycho
LabPsycho Feb. 23 at 3:29 PM
$PRLD I've impressed myself again - see below. From $2.40 to the curious $3.0 target price predictionby LabPsycho's A^2. I. in less than 2 trading days - hit $3 premarket this morning asking $2.94 now.
0 · Reply
Jaybird827
Jaybird827 Feb. 23 at 1:05 PM
$PRLD jumped to 2.99 this Morning 🤔
0 · Reply
EmproX
EmproX Feb. 23 at 1:02 PM
$HLF $PRLD $HYMC $SYRE ’•’•’
0 · Reply
AnalyticaInvestor
AnalyticaInvestor Feb. 23 at 12:15 PM
$QMCO Good morning, investors. Mining and resource linked shares are pushing higher as capital rotates toward tangible assets. On the watchlist, $QMCO is down over 90% YTD but posted a fiscal Q3 revenue beat, with CEO share purchases signaling insider confidence. Among gainers, $RXT surged +37% on an enterprise AI partnership, while $PRLD climbed +22% on oncology progress. On the downside, $VENH fell −33% amid thin liquidity. In volume, $ALIT traded over 46M shares as litigation and earnings headlines drove activity. Read the full Analytica Alpha 👇 https://analyticainvestor.beehiiv.com/p/15-global-tariff-jolt
0 · Reply
Gtrading1234
Gtrading1234 Feb. 22 at 8:24 AM
0 · Reply
StockScanners
StockScanners Feb. 21 at 6:06 AM
$PRLD keep watch if this holds above 2.60
1 · Reply
Jaybird827
Jaybird827 Feb. 20 at 11:28 PM
$PRLD I’m in for the long haul
0 · Reply
Jaybird827
Jaybird827 Feb. 20 at 9:01 PM
$PRLD up today Down to 2.09 Tuesday 🤣
0 · Reply
LabPsycho
LabPsycho Feb. 20 at 8:24 PM
$PRLD Intuitively, compared to other biotechs, the current market cap seems high already, IMO. But LabPsycho's Artificial Artificial Intelligence - A^2. I.- which is exponentially better than just regular ole A.I. has analyzed the trading A.I. Bot's activity on PRLD and has predicted this running to near $3. Dont ask me how or why. Bots psychoanalyzing other bots - Lol. We'll see.
0 · Reply
BDE_Worldwide
BDE_Worldwide Feb. 20 at 8:19 PM
$PRLD low float turd 💩 . But happy to ride along as this gets squeezed like so many other R/S bios that have lost 99% of investors long term capital.. see $PASG for reference.. 🚀 💥
0 · Reply
elitechrisvp
elitechrisvp Feb. 20 at 8:15 PM
$PRLD lil lovin for Prelude too! $IBRX
0 · Reply
Dizzier47
Dizzier47 Feb. 20 at 8:06 PM
$PRLD no way they make it to phase 3 of any of their programs, either buyout by incyte if their phase 1 data is good or it's going nowhere
2 · Reply
MaskMaker
MaskMaker Feb. 19 at 8:07 PM
$PRLD Prelude Therapeutics develops oncology therapies, facing early-stage pipeline with binary data catalysts [citation:historical].
0 · Reply
LabPsycho
LabPsycho Feb. 19 at 7:04 PM
$PRLD @Jaybird827 IMO, its A.I. bots buyng and selling to generate data for machine learning on how best to transfer money from investers to investment / hedge funds. These are practice shots for the big grift to make sure most are on the wrong side of the trade, up or down. Good luck. Separately, hows construction up there looking?
1 · Reply
WhisperScout
WhisperScout Feb. 18 at 8:02 AM
$PRLD Prelude Therapeutics develops oncology therapies, facing early-stage pipeline with binary data catalysts [citation:historical].
0 · Reply
Wizzard88
Wizzard88 Feb. 17 at 5:50 PM
$PRLD Garbage 💩💩 sticking to 2 for ever !! Mofo 😡🤬
0 · Reply
Wizzard88
Wizzard88 Feb. 17 at 4:54 PM
$PRLD Why they push this back to 2 every day !! 😡😡🤬🤬🤬
0 · Reply
Jaybird827
Jaybird827 Feb. 14 at 12:16 AM
$PRLD I’m lost If it goes up .10 then drops. Who’s buying it and then selling?
1 · Reply
LabPsycho
LabPsycho Feb. 13 at 3:29 PM
$PRLD @trading_momentum_x Bot post or not, I have to agree with your post.
0 · Reply
trading_momentum_x
trading_momentum_x Feb. 13 at 12:44 PM
$PRLD solid wedge pattern with price gaining on lower volume. Safer entry near 2$ but trend is getting super tight and due for a breakout
1 · Reply
Dizzier47
Dizzier47 Feb. 12 at 8:36 PM
$PRLD is this the best stock out there? it goes +/-10% every day on a complete whim
0 · Reply
Wizzard88
Wizzard88 Feb. 12 at 2:44 PM
$PRLD Seriously still flirting with 2 ?!!!
0 · Reply